Advertisement
Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
 QUICK SEARCH:   [advanced]


     


Parkinson's disease/Parkinsonism

Citations 241-250 of 519 total displayed.

Past content (since Jan 2000):

ARTICLES
Cognitive profile of patients with newly diagnosed Parkinson disease
Dino Muslimovic, Bart Post, Johannes D. Speelman, and Ben Schmand
Neurology 2005; 65: 1239-1245. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Analysis of LRRK2 functional domains in nondominant Parkinson disease
L. Skipper, H. Shen, E. Chua, C. Bonnard, P. Kolatkar, L.C.S. Tan, R. D. Jamora, K. Puvan, K. Y. Puong, Y. Zhao, R. Pavanni, M. C. Wong, Y. Yuen, M. Farrer, J. J. Liu, and E. K. Tan
Neurology 2005; 65: 1319-1321. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports
Samuel Frank, Karl Kieburtz, Robert Holloway, and Scott Y.H. Kim
Neurology 2005; 65: 1101-1103. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies
D. Devos, M. Tir, C. A. Maurage, N. Waucquier, L. Defebvre, S. Defoort-Dhellemmes, and A. Destée
Neurology 2005; 65: 1107-1110. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease
G. Koch, L. Brusa, C. Caltagirone, A. Peppe, M. Oliveri, P. Stanzione, and D. Centonze
Neurology 2005; 65: 623-625. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Botulinum toxin injections do not improve freezing of gait in Parkinson disease
Marguerite Wieler, Richard Camicioli, C. Allyson Jones, and W. R. Wayne Martin
Neurology 2005; 65: 626-628. [Abstract] [Full text] [PDF]  

VIEWS & REVIEWS
Camptocormia: Pathogenesis, classification, and response to therapy
Shaheda N. Azher and Joseph Jankovic
Neurology 2005; 65: 355-359. [Abstract] [Full text] [PDF]  

ARTICLES
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease
R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, V. McGuire, A. L. Bernstein, D. A. Bloch, A. Leimpeter, and L. M. Nelson
Neurology 2005; 65: 383-390. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Reduced amplitude of the sural nerve sensory action potential in PARK2 patients
Y. Ohsawa, K. Kurokawa, M. Sonoo, H. Yamada, S. Hemmi, K. Iwatsuki, H. Hagiwara, T. Murakami, T. Shirabe, T. Shimizu, and Y. Sunada
Neurology 2005; 65: 459-462. [Abstract] [Full text] [PDF]  

CORRECTIONS
Correction
Neurology 2005; 65: 462. [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

* Collected Resources Home

* Related collections:
 Movement Disorders
 All Movement Disorders
 Dystonia
 Blepharospasm
 Gait disorders/ataxia
 Cerebellum
 Huntington's disease
 Basal ganglia
 Parkinson's disease/Parkinsonism
 Motor Control
 Progressive supranuclear palsy
 Motor cortex
 Stiff person syndrome
 Surgery/Stimulation
 Tourette syndrome
 Tremor
 Tics
 Chorea
 Botulinum toxin
 Multiple system atrophy
 Rett Syndrome
 Myoclonus
 Spastic paraplegia


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Copyright © 2009 by AAN Enterprises, Inc.
Advertisement